Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Harrison

Showing results (181-190 of 186) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 186 results.
British Journal of Pharmacology|June 6, 2007
Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomersB Bingham, P G Jones, A J Uveges, et al.
Respiratory Medicine|October 30, 1999
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhalerD I Bernstein, R B Berkowitz, P Chervinsky, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 5, 2000
Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthmaA S Nayak, C Banov, J Corren, et al.
Neuropharmacology|May 4, 2012
Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depressionZ A Hughes, S J Neal, D L Smith, et al.
British Journal of Pharmacology|July 2, 2010
WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depressionG T Whiteside, J M Dwyer, J E Harrison, et al.
The Journal of Allergy and Clinical Immunology|November 18, 2000
Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthmaJ E Fish, J P Karpel, T J Craig, et al.
Pageof 19

Showing results (181-190 of 186) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 186 results.
British Journal of Pharmacology|June 6, 2007
Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomersB Bingham, P G Jones, A J Uveges, et al.
Respiratory Medicine|October 30, 1999
Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhalerD I Bernstein, R B Berkowitz, P Chervinsky, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 5, 2000
Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthmaA S Nayak, C Banov, J Corren, et al.
Neuropharmacology|May 4, 2012
Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depressionZ A Hughes, S J Neal, D L Smith, et al.
British Journal of Pharmacology|July 2, 2010
WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depressionG T Whiteside, J M Dwyer, J E Harrison, et al.
The Journal of Allergy and Clinical Immunology|November 18, 2000
Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthmaJ E Fish, J P Karpel, T J Craig, et al.
Pageof 19